Global Neurology Academy
The Global Neurology Academy (GNA) Series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Episodes 1-15 of 37
Factoring Solutions to the Management of Stroke Care in the Settings of Secondary Prevention and AF
CME/CE Broadcast ReplayFactoring Solutions to the Management of Stroke Care in the Settings of Secondary Prevention and AF
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
CME/CEPatient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
From Pathology to Practice: The Role of Inflammation in MS Pathology
MinuteCE®From Pathology to Practice: The Role of Inflammation in MS Pathology
Balancing Act: Immune Reconstitution vs Immune Suppression
MinuteCE®Balancing Act: Immune Reconstitution vs Immune Suppression
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
MinuteCE®MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
MinuteCE®Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
Long-Term Safety of DMTs: What We Know and What We Need to Know
MinuteCE®Long-Term Safety of DMTs: What We Know and What We Need to Know
Fluid Biomarkers: Revolutionizing MS Diagnosis
MinuteCE®Fluid Biomarkers: Revolutionizing MS Diagnosis
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
CME/CESpinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
CME/CEEvolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
